Stocktoria
Anebulo Pharmaceuticals, Inc. ANEB
OTC · stock · Pharmaceutical Preparations · website · IPO 2021-05-07
Anebulo Pharmaceuticals, Inc. statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -69.9% | -201.4% | -100.5% | -43.8% | -139.7% |
| Return on equity | -72.8% | -215.1% | -110.7% | -45.3% | -141.3% |
Source: SEC EDGAR filings · CIK 0001815974 · US · as of 2025-06-30. facts plus Stocktoria's own computed scores — not investment advice.